InvestorsHub Logo

Globaltrnr

03/15/12 12:19 PM

#2223 RE: brick1981 #2222

This opens the door to nice cheapies...

ErnieBilco

03/15/12 12:59 PM

#2224 RE: brick1981 #2222

I thought Deerfield had a .99 floor for selling.

Rosco22

03/15/12 6:11 PM

#2233 RE: brick1981 #2222

Bud an investor I am not, I trade. I react to price action, if you want to invest and look for that "home run" go ahead. Due diligence?....I spent 8yrs on hedge fund desk, its all in the tape...thats my due diligence, nowadays I trade for me and keep it quiet for most part. Im not going to find a reason to justify the action or lack of. I hope this thing does turn and rip. Its just been a distraction for me lately, I expected it to be through the flip top at this point but it seems to lack enthusiasm from players. Gl guys

cadillac107

03/15/12 7:24 PM

#2234 RE: brick1981 #2222

One has to make the distinction as to whether he has a long term orientation, or whether he is short term focused for a quick trade. Bear in mind that the market is more an art than a science. If one has been a patient long term investor, he no doubt has been holding his position in anticipation of FDA approval of any of TLON's potential block buster drugs. If you've held this stock and fall in this category, then relax as big money is also betting on this development as well, as we enter "the home stretch". However, if one is strictly here for a quick trade and is trying to time the market. one may have to exercise a bit more patience then was originally thought. Remember that Rome was not built in a day, and if this was a sure thing, the company's stock would not be priced where it is. The FDA new drug process is long and tedious, especially in its scrutinizing of smaller firms. For starters, from a technical stand point, one may want to put in a mental stop order at around forty cents, as a break in price below this figure would indicate that a major support area has been breached, which could be a reflection of a serious deterioration in the drugs outlook to receive approval.